| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 142 | 0 | 0 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 142 | 0 | 32 |
| Total Expenses - EUR | - | - | - | - | - | - | 15.240 | 28.585 | 12.382 | 1.039 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -15.240 | -28.443 | -12.382 | -1.007 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -15.240 | -28.447 | -12.382 | -1.007 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Neolaser Ozmedical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 2.659 | 2.119 | 1.631 | 1.274 |
| Current Assets | - | - | - | - | - | - | 5.703 | 631 | 1.049 | 1.187 |
| Inventories | - | - | - | - | - | - | 144 | 38 | 37 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 0 | 882 | 877 |
| Cash | - | - | - | - | - | - | 5.559 | 594 | 130 | 310 |
| Shareholders Funds | - | - | - | - | - | - | -16.729 | -45.228 | -57.473 | -58.159 |
| Social Capital | - | - | - | - | - | - | 101 | 101 | 101 | 101 |
| Debts | - | - | - | - | - | - | 25.091 | 47.977 | 60.153 | 60.620 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neolaser Ozmedical S.r.l.